BBIO

NASDAQStock

BridgeBio Pharma, Inc.

$68.82-2.76 (-3.87%)

52-Week Range

$30.14
$79.91

Key Stats

Market Cap

13.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Volume

1.6M

Avg Volume

3.2M

Performance

1M

-6.20%

3M

-9.54%

6M

+32.08%

YTD

-13.11%

1Y

+108.59%

3Y

+367.86%

5Y

-2.73%

Price Chart

ETF Exposure

BBIO is held by 120 ETFs

ETFFund NameWeight
HELXFranklin Genomic Advancements ETF4.18%
CANCTema Oncology ETF3.97%
HRTSTema Cardiovascular and Metabolic ETF2.88%
PTHInvesco Dorsey Wright Healthcare Momentum ETF2.40%
BBPVirtus Biotech ETF1.51%
FSMLFranklin Small Cap Enhanced ETF1.43%
JSMLJanus Henderson Small Cap Growth Alpha ETF1.30%
XBIState Street SPDR S&P Biotech ETF1.25%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF1.22%
IPORenaissance IPO ETF1.20%
IBBQInvesco Nasdaq Biotechnology ETF1.09%
IBBiShares Biotechnology ETF1.06%
FPXFirst Trust US Equity Opportunities ETF1.06%
PDPInvesco Dorsey Wright Momentum ETF0.95%
IWOiShares Russell 2000 Growth ETF0.93%
GSCGoldman Sachs Small Cap Equity ETF0.91%
GDOCGoldman Sachs Future Health Care Equity ETF0.82%
SGRWHarbor Active Small Cap Growth ETF (SGRW)0.80%
ACSGAmerican Century Small Cap Growth Insights ETF0.77%
VTWGVanguard Russell 2000 Growth ETF0.77%
BIBProShares - Ultra Nasdaq Biotechnology0.74%
QQQJInvesco NASDAQ Next Gen 100 ETF0.73%
CVRTCalamos Convertible Equity Alternative ETF0.72%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF0.71%
ILDRFirst Trust Innovation Leaders ETF0.71%
FNYFirst Trust Mid Cap Growth AlphaDEX Fund0.70%
FDMOFIDELITY MOMENTUM FACTOR ETF0.66%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.57%
WDNAWisdomTree BioRevolution Fund0.55%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.54%
SFYXSoFi Next 500 ETF0.45%
VBKVanguard Small-Cap Growth ETF0.41%
IWMiShares Russell 2000 ETF0.40%
RESMColumbia Research Enhanced Small Cap ETF0.40%
VTWOVanguard Russell 2000 ETF0.39%
ISCGiShares Morningstar Small-Cap Growth ETF0.37%
JKKiShares Morningstar Small-Cap Growth ETF0.37%
RSSLGlobal X - Russell 2000 ETF0.35%
FNXFirst Trust Mid Cap Core AlphaDEX Fund0.35%
VFMOVanguard U.S. Momentum Factor ETF0.33%
STXMStrive Mid-Cap ETF0.33%
SCHASchwab U.S. Small-Cap ETF0.31%
NXTISimplify NEXT Intangible Core Index ETF0.31%
USVMVictoryShares US Small Mid Cap Value Momentum ETF0.30%
FESMFIDELITY ENHANCED SMALL CAP ETF0.30%
PBPHPortfolio Building Block World Pharma and Biotech Index ETF0.30%
UWMProShares - Ultra Russell20000.27%
SCHMSchwab U.S. Mid-Cap ETF0.26%
PWSPacer WealthShield ETF0.26%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.25%
Page 1 of 3Next

About BBIO ETF Exposure

BridgeBio Pharma, Inc. (BBIO) is held by 120 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.3B, BBIO is a widely held institutional stock. The stock currently trades at $68.82. Investors can gain exposure to BBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBIO, sorted by portfolio weight.